Targeting a Tau Kinase Cdk5, Cyclin-Dependent Kinase: A Blood-Based Diagnostic Marker and Therapeutic Earmark for Alzheimer’s Disease. Here, CDK5 is linked to early-onset autosomal dominant Alzheimer disease.